Belimumab for systemic lupus erythematosus Reply

被引：1
|
作者：
Petri, Michelle A. [1 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD 21205 USA
来源：
LANCET | 2011年 / 377卷 / 9783期
关键词：
D O I：
10.1016/S0140-6736(11)60913-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2080 / 2081
页数：2
相关论文
共 50 条
  • [31] Belimumab: A Guide to Its Use in Systemic Lupus Erythematosus
    Scott, Lesley J.
    Burness, Celeste B.
    McCormack, Paul L.
    BIODRUGS, 2012, 26 (03) : 195 - 199
  • [32] EFFICACY AND SAFETY OF BELIMUMAB FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS
    Borba, H. H. L.
    Wiens, A.
    Correr, C. J.
    Pontarolo, R.
    VALUE IN HEALTH, 2013, 16 (07) : A725 - A726
  • [33] Successful treatment of systemic lupus erythematosus pleuropericarditis with belimumab
    Carrion-Barbera, Irene
    Carlos Salman-Monte, Tarek
    Castell, Sonia
    Castro-Dominguez, Francisco
    Ojeda, Fabiola
    Monfort, Jordi
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2019, 6 (03) : 150 - 152
  • [34] Belimumab in systemic lupus erythematosus: a profile of its use
    Lamb, Yvette N.
    DRUGS & THERAPY PERSPECTIVES, 2021, 37 (01) : 1 - 12
  • [35] Belimumab: A Guide to Its Use in Systemic Lupus Erythematosus
    Lesley J. Scott
    Celeste B. Burness
    Paul L. McCormack
    BioDrugs, 2012, 26 : 195 - 199
  • [36] Belimumab and antipneumococcal vaccination in patients with systemic lupus erythematosus
    Azoicai, Tudor
    Antoniu, Sabina
    Caruntu, Irina Draga
    Azoicai, Doina
    Antohe, Ileana
    Gavrilovici, Cristina
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (03) : 175 - 177
  • [37] Systemic lupus erythematosus - Reply
    Isenberg, David A.
    Rahman, Anisur
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (22): : 2413 - 2413
  • [38] SYSTEMIC LUPUS ERYTHEMATOSUS - REPLY
    BROWN, CH
    GASTROENTEROLOGY, 1958, 34 (05) : 921 - 923
  • [39] Systemic Lupus Erythematosus REPLY
    Tsokos, George C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (06): : 574 - 574
  • [40] Belimumab plasma concentration associated with systemic lupus erythematosus activity
    Moyon, Q.
    Cougnaud, R.
    Mathian, A.
    Cohen, F.
    Pha, M.
    Marin, C.
    Mansour, B.
    Noe, G.
    Amoura, Z.
    Zahr, N.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 158 - 158
12345